Page last updated: 2024-09-04

febuxostat and 2-naphthol

febuxostat has been researched along with 2-naphthol in 1 studies

Compound Research Comparison

Studies (febuxostat)	Trials (febuxostat)	Recent Studies (post-2010) (febuxostat)	Studies (2-naphthol)	Trials (2-naphthol)	Recent Studies (post-2010) (2-naphthol)
818	133	710	4,120	16	1,458

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Baek, CH; Chang, JW; Kim, H; Lee, SK; Yang, WS	1

Other Studies

1 other study(ies) available for febuxostat and 2-naphthol

Article	Year
Febuxostat, a novel inhibitor of xanthine oxidase, reduces ER stress through upregulation of SIRT1-AMPK-HO-1/thioredoxin expression. Clinical and experimental nephrology, 2020, Volume: 24, Issue:3 Topics: AMP-Activated Protein Kinases; Animals; Benzamides; Cell Line; Drug Evaluation, Preclinical; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Febuxostat; Heme Oxygenase-1; Humans; Mice; Naphthols; Renal Insufficiency, Chronic; Signal Transduction; Sirtuin 1; Thioredoxins; Tunicamycin; Xanthine Oxidase	2020

Article

Year

Febuxostat, a novel inhibitor of xanthine oxidase, reduces ER stress through upregulation of SIRT1-AMPK-HO-1/thioredoxin expression.

Clinical and experimental nephrology, 2020, Volume: 24, Issue:3

Topics: AMP-Activated Protein Kinases; Animals; Benzamides; Cell Line; Drug Evaluation, Preclinical; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Febuxostat; Heme Oxygenase-1; Humans; Mice; Naphthols; Renal Insufficiency, Chronic; Signal Transduction; Sirtuin 1; Thioredoxins; Tunicamycin; Xanthine Oxidase

2020